comprehensive -WSS

comprehensive

author：entertainment 2025-09-27 12:34:35 - browse：63

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： As a primary care physician, here's how I hope to partner with AI

focus

hotspot

WSS

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Anavex keeps shifting the goalposts in its clinical trials

Eyeing GLP

Friends ask where James Watson's attitudes about race came from

Police still searching for prisoner who escaped from NYC hospital

H5N1 virus can be tracked in retail milk, scientists say

focus

comprehensive

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Bright Health sells Medicare Advantage business to Molina

Making the case for fair compensation in clinical trials

Medical records are filled with copy

Addressing health care workers' trauma can help fight burnout

Anesthesiologist group: stop taking Ozempic before surgery

Maui's cultural, historic landmarks damaged in the devastating wildfires

Affirmative action in medical school literally saved lives

Methadone doses haven’t kept up in the age of fentanyl

Wikipedia

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Reports of telehealth's death have been greatly exaggerated

What to know about Virgin Galactic's 1st mission taking paying customers to space

Investigation reveals sickle cell patients pressured into sterilizations

Reports of telehealth's death have been greatly exaggerated

Eyeing GLP

focus

focus

hotspot

knowledge